{"id":1063181,"date":"2010-06-03T08:18:08","date_gmt":"2010-06-03T08:18:08","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/phase-i-clinical-trial-of-ict-107\/"},"modified":"2024-08-17T20:27:38","modified_gmt":"2024-08-18T00:27:38","slug":"phase-i-clinical-trial-of-ict-107","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/phase-i-clinical-trial-of-ict-107.php","title":{"rendered":"Phase I clinical trial of ICT-107"},"content":{"rendered":"

Immune response correlation with progression-free survival in glioblastoma following dendritic cell immunotherapy (ICT-107)<\/a> by Surasak Phuphanich<\/a> and 9 co-authors, including Manish Singh<\/a>, Keith Black<\/a> and John Wu<\/a>, J Clin Oncol<\/em> 28:7s, 2010 (suppl; abstr 2097). To be presented at the 2010 ASCO Annual Meeting<\/a>, June 06, 2010.<\/p>

Related news releases:<\/p>

ImmunoCellular Therapeutics Ltd. (IMUC) to Present Cancer Vaccine Candidate<\/a>, International Business Times<\/em>, June 02, 2010. Excerpt:<\/p>

Data from the company’s recent clinical trial of ICT-107, the company’s dendritic cell-based cancer vaccine candidate, will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) June 4-8 in Chicago.<\/p><\/blockquote>

See also: Immunocellular brain cancer vaccine shows promise<\/a>, Reuters<\/em>, June 02, 2010. Excerpt: <\/p>

\"We are targeting specific antigens that are on cancer stem cells ... the only population of cells that can really propagate a tumor,\" said Dr. John Yu, director of surgical neuro-oncology at Cedars-Sinai Medical Center in Los Angeles and ImmunoCellular's chief scientific officer.<\/p><\/blockquote>

Another related news release: Immunocellular Therapeutics Enters into Research Agreement with University of Pennsylvania to Support Phase II Clinical Trial of ICT-107<\/a>, Business Wire<\/em>, April 21, 2010.<\/p>

\"\"<\/div>","protected":false},"excerpt":{"rendered":"

Immune response correlation with progression-free survival in glioblastoma following dendritic cell immunotherapy (ICT-107) by Surasak Phuphanich and 9 co-authors, including Manish Singh, Keith Black and John Wu, J Clin Oncol 28:7s, 2010 (suppl; abstr 2097). To be presented at the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25,1246878],"tags":[],"class_list":["post-1063181","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy","category-stem-cells"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063181"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1063181"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063181\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1063181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1063181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1063181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}